tiprankstipranks
Advertisement
Advertisement

ASP Isotopes Subsidiary Adds Expert to Advisory Board

Story Highlights
  • ASP Isotopes’ subsidiary Quantum Leap Energy appointed Dr. Peter Fiske to its Strategic Advisory Board on May 6, 2026.
  • The move strengthens QLE’s government, defense, and energy-sector ties as it builds momentum commercializing advanced nuclear fuel technologies for next-generation reactors.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
ASP Isotopes Subsidiary Adds Expert to Advisory Board

Claim 55% Off TipRanks

ASP Isotopes, Inc. ( (ASPI) ) has shared an update.

On May 6, 2026, ASP Isotopes announced that its wholly owned subsidiary Quantum Leap Energy appointed technology commercialization specialist Dr. Peter S. Fiske to QLE’s Strategic Advisory Board. His background spans leadership roles at the National Alliance for Water Innovation, advanced materials research at Lawrence Livermore National Laboratory, and executive and entrepreneurial posts in water and semiconductor-related technologies.

The appointment follows QLE’s recent formation of its advisory board, the naming of a chief technology officer, and a collaboration with the University of Bristol, highlighting accelerating organizational development at the subsidiary. Dr. Fiske’s deep network in U.S. government, defense contracting, and energy-sector partnerships is expected to strengthen QLE’s access to public funding and institutional customers, bolstering its efforts to commercialize advanced nuclear fuel technologies for fission, fusion, and next-generation reactor markets.

The most recent analyst rating on (ASPI) stock is a Buy with a $11.00 price target. To see the full list of analyst forecasts on ASP Isotopes, Inc. stock, see the ASPI Stock Forecast page.

Spark’s Take on ASPI Stock

According to Spark, TipRanks’ AI Analyst, ASPI is a Neutral.

The score is held back primarily by weak financial quality (losses and high leverage) despite strong revenue growth. Technicals are neutral-to-slightly constructive near-term but weaker longer-term, and valuation remains challenging due to negative earnings and no dividend yield support. Earnings-call and corporate updates add some upside optionality via new facilities/contracts and recent strategic actions, but execution and guidance uncertainty keep the overall score below average.

To see Spark’s full report on ASPI stock, click here.

More about ASP Isotopes, Inc.

ASP Isotopes Inc. is an advanced materials company focused on developing isotope enrichment technologies to strengthen global supply chains for critical materials used in nuclear medicine, next-generation semiconductors, and nuclear energy. Through its proprietary Aerodynamic Separation Process and Quantum Enrichment technologies, the company operates enrichment facilities in Pretoria, South Africa, and serves industrial and advanced technology markets via its subsidiary Quantum Leap Energy, a development-stage nuclear fuels company targeting both front-end and back-end segments of the nuclear fuel cycle.

Average Trading Volume: 4,373,654

Technical Sentiment Signal: Sell

Current Market Cap: $649.7M

Learn more about ASPI stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1